1. Home
  2. NTHI vs ZJYL Comparison

NTHI vs ZJYL Comparison

Compare NTHI & ZJYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • ZJYL
  • Stock Information
  • Founded
  • NTHI 2008
  • ZJYL 2006
  • Country
  • NTHI United States
  • ZJYL China
  • Employees
  • NTHI N/A
  • ZJYL N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • ZJYL Industrial Specialties
  • Sector
  • NTHI Health Care
  • ZJYL Consumer Discretionary
  • Exchange
  • NTHI Nasdaq
  • ZJYL Nasdaq
  • Market Cap
  • NTHI 110.9M
  • ZJYL 100.3M
  • IPO Year
  • NTHI N/A
  • ZJYL 2023
  • Fundamental
  • Price
  • NTHI $5.12
  • ZJYL $0.61
  • Analyst Decision
  • NTHI
  • ZJYL
  • Analyst Count
  • NTHI 0
  • ZJYL 0
  • Target Price
  • NTHI N/A
  • ZJYL N/A
  • AVG Volume (30 Days)
  • NTHI 320.0K
  • ZJYL 258.4K
  • Earning Date
  • NTHI 01-01-0001
  • ZJYL 08-26-2025
  • Dividend Yield
  • NTHI N/A
  • ZJYL N/A
  • EPS Growth
  • NTHI N/A
  • ZJYL 18.46
  • EPS
  • NTHI N/A
  • ZJYL 0.02
  • Revenue
  • NTHI $79,990.00
  • ZJYL $23,502,010.00
  • Revenue This Year
  • NTHI N/A
  • ZJYL N/A
  • Revenue Next Year
  • NTHI N/A
  • ZJYL N/A
  • P/E Ratio
  • NTHI N/A
  • ZJYL $26.11
  • Revenue Growth
  • NTHI 13.52
  • ZJYL 18.57
  • 52 Week Low
  • NTHI $3.20
  • ZJYL $0.50
  • 52 Week High
  • NTHI $25.00
  • ZJYL $4.08
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • ZJYL 41.23
  • Support Level
  • NTHI N/A
  • ZJYL $0.63
  • Resistance Level
  • NTHI N/A
  • ZJYL $0.68
  • Average True Range (ATR)
  • NTHI 0.00
  • ZJYL 0.03
  • MACD
  • NTHI 0.00
  • ZJYL -0.00
  • Stochastic Oscillator
  • NTHI 0.00
  • ZJYL 16.54

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About ZJYL JIN MEDICAL INTERNATIONAL LTD.

Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.

Share on Social Networks: